Certain psychiatric drugs may increase risk of pneumonia

NewsGuard 100/100 Score
Editorial Checklist Reviewed

A review of published studies indicates that use of benzodiazepines and benzodiazepine related drugs (BZRDs), which are prescribed to treat various psychiatric diseases, may increase the risk of pneumonia.

The International Journal of Geriatric Psychiatry analysis included 12 reports related to 10 studies involving more than 120,000 pneumonia cases. After pooling the estimates, the odds for developing pneumonia were 1.25-fold higher in BZRD users compared with individuals who had not taken BZRDs.

There was an increased risk of pneumonia among current and recent users, but not past users.

Source:

https://newsroom.wiley.com/press-release/international-journal-geriatric-psychiatry/certain-psychiatric-drugs-linked-elevated-p

Posted in: Medical Research News | Disease/Infection News | Pharmaceutical News

Tags: , ,

Comments (0)

Suggested Reading

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity
Rapid molecular testing transforms treatment for community-acquired pneumonia
New hope for binge eating and bulimia: GLP-1 drugs could be the key
Study links pneumonia transmission in seniors to contact with young children
New study reveals effective strategies against drug resistance in hospital-acquired pneumonia treatment
Understanding antimicrobial resistance in hospital-acquired pneumonia
Researchers uncover how deadly MRSA pneumonia inhibits body's antimicrobial activity
Study finds erectile dysfunction drugs linked to lower Alzheimer's risk

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings